Obesity has become one of the strongest non-traditional drivers of chronic kidney disease (CKD) worldwide. As body fat (or adipose in medical terms) increases, it sets off a cascade of metabolic, hemodynamic, and inflammatory disturbances that begin to erode your kidney's structure and function. These changes occur silently at first, progressing over years until the kidneys can no longer compensate.
Excess adipose tissue raises renal blood flow and glomerular filtration rate, causing persistent hyperfiltration[1]. This injures glomerular capillaries, leading to scarring and progressive loss of nephrons. Adipose tissue also acts as an endocrine organ, releasing pro-inflammatory cytokines such as TNF‑α, IL‑6, and leptin. It results in endothelial dysfunction, which is a hallmark for vascular diseases.
Insulin resistance, common in obesity, worsens the problem even more by causing hyperinsulinemia, sodium retention, sympathetic activation, and over-stimulation of the renin–angiotensin–aldosterone system (RAAS), a hormone system that regulates blood pressure/fluid/electrolyte balance, and also systemic vascular resistance[2]. This accelerates kidney damage.
Early signs are often subtle: microalbuminuria, borderline hypertension, and mildly elevated creatinine. As the disease progresses, proteinuria increases and glomerular filtration rate declines. Unlike traditional Chronic Kidney Disease from diabetes or hypertension, obesity-related kidney disease can occur even without those conditions[3].
Obese individuals face up to a four-fold higher risk, independent of diabetes or hypertension.
Management centers on weight reduction through diet, exercise, bariatric surgery, or prescribing GLP-1 medication, which improves filtration and reduces proteinuria. RAAS inhibitors help lower glomerular pressure, while controlling insulin resistance and lipids slows progression. Early screening with microalbuminuria and estimated GFR testing is essential for timely intervention.
We propose naming this Adiposity-Induced Chronic Kidney Disease, a form of CKD of non-traditional causes.
[1] Di Lorenzo et al: Hyperfiltration in Obesity: The Vicious Link Between Visceral Fat, Proteinuria, and Sodium Excretion in Nutrients - 2026
[2] Röster, Wolff: The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases in Seminars in Nephrology - 2013
[3] Hao et al: The New Challenge of Obesity - Obesity-Associated Nephropathy in Diabetes, Metabolic Syndrome and Obesity - 2024

No comments:
Post a Comment